Researchers say the results point to a potential shift in how obesity is treated—as a central disease driving multiple conditions, rather than a collection of separate problems
Exclusive Asia-Pacific licensing agreement for Bejescin strengthens the company’s nephrology and autoimmune disease portfolio
The greenfield facility in Madhya Pradesh expected to create up to 500 direct jobs, in addition to generating indirect employment opportunities
Investigational once-weekly GLP-1 and amylin receptor agonist achieves up to 14.6% weight loss and significant blood sugar reductions
Amitabh Dube and Sheetal Arora named Co-Chairmen for the forthcoming term
Ranluspec is the only interchangeable ranibizumab biosimilar approved in the United States in both vial and pre-filled syringe (PFS) presentations
Rahul brings over 17 years of experience in human resources leadership across the healthcare, banking, information technology, and FMCG sectors
Company expands injectable portfolio with therapeutically equivalent version of Vimpat®, targeting a market valued at approximately $15.2 million annually
MSD joins as anchor customer as Aurobindo strengthens its position in the fast-growing global biologics manufacturing market
The company recycled approximately 100 kilograms of textile waste, undertook plantation activities, and encouraged employees to adopt environmentally responsible practices
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
